PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND
Use of an aldehyde-based compound as represented by general formula I, a pharmaceutical composition, a pharmaceutical salt, an enantiomer, a diastereomer and a racemic compound thereof as a novel coronavirus 2019 (2019-nCov) 3CL protease inhibitor in preparation of a medicament for treating and/or p...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XIE, Xiong HU, Shulei SU, Haixia CHEN, Kaixian ZHANG, Leike YANG, Haitao XIAO, Gengfu XU, Yechun PENG, Jingjing LI, Jian LIU, Hong JIN, Zhenming JIANG, Hualiang DAI, Wenhao LI, Chunpu |
| description | Use of an aldehyde-based compound as represented by general formula I, a pharmaceutical composition, a pharmaceutical salt, an enantiomer, a diastereomer and a racemic compound thereof as a novel coronavirus 2019 (2019-nCov) 3CL protease inhibitor in preparation of a medicament for treating and/or preventing and relieving respiratory tract infections, pneumonia and other related diseases caused by the novel coronavirus infection 2019. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023138310A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023138310A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023138310A13</originalsourceid><addsrcrecordid>eNrjZNAN8HAM8nV0dg0N8XR29FEIDXZV8HdTcPRxcfWIdHHVdXIMdnVRcPb3DfAP9XPhYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkbGhsYWxoYGjobGxKkCAED7Jiw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND</title><source>esp@cenet</source><creator>XIE, Xiong ; HU, Shulei ; SU, Haixia ; CHEN, Kaixian ; ZHANG, Leike ; YANG, Haitao ; XIAO, Gengfu ; XU, Yechun ; PENG, Jingjing ; LI, Jian ; LIU, Hong ; JIN, Zhenming ; JIANG, Hualiang ; DAI, Wenhao ; LI, Chunpu</creator><creatorcontrib>XIE, Xiong ; HU, Shulei ; SU, Haixia ; CHEN, Kaixian ; ZHANG, Leike ; YANG, Haitao ; XIAO, Gengfu ; XU, Yechun ; PENG, Jingjing ; LI, Jian ; LIU, Hong ; JIN, Zhenming ; JIANG, Hualiang ; DAI, Wenhao ; LI, Chunpu</creatorcontrib><description>Use of an aldehyde-based compound as represented by general formula I, a pharmaceutical composition, a pharmaceutical salt, an enantiomer, a diastereomer and a racemic compound thereof as a novel coronavirus 2019 (2019-nCov) 3CL protease inhibitor in preparation of a medicament for treating and/or preventing and relieving respiratory tract infections, pneumonia and other related diseases caused by the novel coronavirus infection 2019.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230504&DB=EPODOC&CC=US&NR=2023138310A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230504&DB=EPODOC&CC=US&NR=2023138310A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XIE, Xiong</creatorcontrib><creatorcontrib>HU, Shulei</creatorcontrib><creatorcontrib>SU, Haixia</creatorcontrib><creatorcontrib>CHEN, Kaixian</creatorcontrib><creatorcontrib>ZHANG, Leike</creatorcontrib><creatorcontrib>YANG, Haitao</creatorcontrib><creatorcontrib>XIAO, Gengfu</creatorcontrib><creatorcontrib>XU, Yechun</creatorcontrib><creatorcontrib>PENG, Jingjing</creatorcontrib><creatorcontrib>LI, Jian</creatorcontrib><creatorcontrib>LIU, Hong</creatorcontrib><creatorcontrib>JIN, Zhenming</creatorcontrib><creatorcontrib>JIANG, Hualiang</creatorcontrib><creatorcontrib>DAI, Wenhao</creatorcontrib><creatorcontrib>LI, Chunpu</creatorcontrib><title>PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND</title><description>Use of an aldehyde-based compound as represented by general formula I, a pharmaceutical composition, a pharmaceutical salt, an enantiomer, a diastereomer and a racemic compound thereof as a novel coronavirus 2019 (2019-nCov) 3CL protease inhibitor in preparation of a medicament for treating and/or preventing and relieving respiratory tract infections, pneumonia and other related diseases caused by the novel coronavirus infection 2019.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAN8HAM8nV0dg0N8XR29FEIDXZV8HdTcPRxcfWIdHHVdXIMdnVRcPb3DfAP9XPhYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkbGhsYWxoYGjobGxKkCAED7Jiw</recordid><startdate>20230504</startdate><enddate>20230504</enddate><creator>XIE, Xiong</creator><creator>HU, Shulei</creator><creator>SU, Haixia</creator><creator>CHEN, Kaixian</creator><creator>ZHANG, Leike</creator><creator>YANG, Haitao</creator><creator>XIAO, Gengfu</creator><creator>XU, Yechun</creator><creator>PENG, Jingjing</creator><creator>LI, Jian</creator><creator>LIU, Hong</creator><creator>JIN, Zhenming</creator><creator>JIANG, Hualiang</creator><creator>DAI, Wenhao</creator><creator>LI, Chunpu</creator><scope>EVB</scope></search><sort><creationdate>20230504</creationdate><title>PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND</title><author>XIE, Xiong ; HU, Shulei ; SU, Haixia ; CHEN, Kaixian ; ZHANG, Leike ; YANG, Haitao ; XIAO, Gengfu ; XU, Yechun ; PENG, Jingjing ; LI, Jian ; LIU, Hong ; JIN, Zhenming ; JIANG, Hualiang ; DAI, Wenhao ; LI, Chunpu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023138310A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>XIE, Xiong</creatorcontrib><creatorcontrib>HU, Shulei</creatorcontrib><creatorcontrib>SU, Haixia</creatorcontrib><creatorcontrib>CHEN, Kaixian</creatorcontrib><creatorcontrib>ZHANG, Leike</creatorcontrib><creatorcontrib>YANG, Haitao</creatorcontrib><creatorcontrib>XIAO, Gengfu</creatorcontrib><creatorcontrib>XU, Yechun</creatorcontrib><creatorcontrib>PENG, Jingjing</creatorcontrib><creatorcontrib>LI, Jian</creatorcontrib><creatorcontrib>LIU, Hong</creatorcontrib><creatorcontrib>JIN, Zhenming</creatorcontrib><creatorcontrib>JIANG, Hualiang</creatorcontrib><creatorcontrib>DAI, Wenhao</creatorcontrib><creatorcontrib>LI, Chunpu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XIE, Xiong</au><au>HU, Shulei</au><au>SU, Haixia</au><au>CHEN, Kaixian</au><au>ZHANG, Leike</au><au>YANG, Haitao</au><au>XIAO, Gengfu</au><au>XU, Yechun</au><au>PENG, Jingjing</au><au>LI, Jian</au><au>LIU, Hong</au><au>JIN, Zhenming</au><au>JIANG, Hualiang</au><au>DAI, Wenhao</au><au>LI, Chunpu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND</title><date>2023-05-04</date><risdate>2023</risdate><abstract>Use of an aldehyde-based compound as represented by general formula I, a pharmaceutical composition, a pharmaceutical salt, an enantiomer, a diastereomer and a racemic compound thereof as a novel coronavirus 2019 (2019-nCov) 3CL protease inhibitor in preparation of a medicament for treating and/or preventing and relieving respiratory tract infections, pneumonia and other related diseases caused by the novel coronavirus infection 2019.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023138310A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T02%3A56%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XIE,%20Xiong&rft.date=2023-05-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023138310A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |